Prostate cancer decisions — 2018

The Board has granted service connection for bilateral hearing loss and tinnitus. The claims for prostate cancer and urinary disability are remanded due to insufficient evidence regarding herbicide agent exposure.

The Board denied service connection for prostate cancer due to lack of evidence linking the condition to active duty, and remanded the skin cancer claim due to insufficient evidence. The Veteran is required to undergo a VA examination.

The Veteran's service-connected disabilities, including major depressive disorder, prostate cancer residuals with prostatectomy residuals, ventral hernia repair residuals, diabetes mellitus, and multiple radiculopathies, make him unable to secure or follow substantially gainful employment. The Board has granted the TDIU.

The Board finds an additional medical opinion is needed to determine if the Veteran's prostate cancer contributed to his death from esophageal cancer. If prostate cancer was a contributing cause, further development will be performed to determine if the Veteran served in Vietnam.

The Veteran's service-connected disabilities were severe enough to render him unable to secure or follow a substantially gainful occupation from June 30, 2009. The Board granted the TDIU effective from June 30, 2009.

The Veteran's right ear hearing loss is not rated higher than the current level.,Tinnitus was awarded an effective date of November 9, 2002.

The Veteran's prostate cancer, status post radiation therapy, was rated at 40 percent from November 1, 2011 through April 12, 2016.

The Veteran's service-connected disabilities, including prostate cancer and depression, have rendered him unable to secure or follow substantially gainful employment since January 12, 2018.

The Veteran's claim for an increased rating in excess of 20 percent for residuals of prostate cancer has been dismissed due to the death of the Veteran.

The Board denied service connection for the claimed disabilities, finding no evidence of herbicide exposure during active duty and thus not meeting the presumptive conditions.

The Board denied service connection for the Veteran's claimed heart condition, prostate cancer, diabetes mellitus type II, and chronic urinary tract condition due to lack of evidence linking these conditions to his military service.

The Veteran's appeals for an increased evaluation and TDIU were dismissed due to his death while the appeal was pending.

The Veteran's claim for an earlier effective date for prostate cancer in remission is denied as there was no prior claim filed before March 28, 2017. The case is being remanded to evaluate the current severity of his service-connected prostate cancer.

The Board has granted service connection for ischemic heart disease, prostate cancer, and diabetes mellitus type II due to exposure to herbicides in the Korean DMZ during active duty.

The Veteran's claim for service connection for various conditions, including hypertension and prostate cancer, was denied. The claim for PTSD received an increased rating to 70 percent effective from April 15, 2015.

The Board has remanded the Veteran's claims for service connection for prostate cancer and anemia due to exposure to ionizing radiation. The claims will be referred to the Under Secretary for Benefits for review under 38 C.F.R. § 3.311, but no action is required at this time as long as the development tasks are completed.

The Board has remanded the claims for service connection for prostate cancer and Parkinson's disease due to herbicide exposure, as it requires further development by the AOJ.

The Veteran's service-connected disabilities, including prostate cancer and non-Hodgkin’s lymphoma with associated peripheral neuropathy, prevent him from securing or following a substantially gainful occupation.

The Veteran's claims for prostate cancer, incontinence as residuals of prostate cancer, erectile dysfunction, and upper teeth disability have all been denied.,Specifically, the Board found that there is no evidence linking these conditions to service.

The Veteran's claims for a higher rating for prostate cancer and erectile dysfunction were denied. The prostate cancer claim was denied as the evidence did not show that the condition had returned, while the erectile dysfunction claim was denied due to lack of compensable criteria.